Article Information
History
- September 5, 2020.
Article Versions
- Version 1 (August 4, 2020 - 11:59).
- You are currently viewing Version 2 of this article (September 5, 2020 - 17:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Riffat Mehboob1,*,
- Fridoon Jawad Ahmad2,
- Ahad Qayyum3,
- Muhammad Asim Rana3,
- Syed Amir Gilani,
- Muhammad Akram Tariq4 and
- Javed Akram2
- 1Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
- 2Deparmtnet of Physiology, University of Health Sciences, Lahore, Pakistan
- 3Bahria International Hospital, Lahore, Pakistan
- 4Higher Education Department Punjab, Lahore, Pakistan
- ↵*Corresponding author details:
Prof. Dr. Riffat Mehboob, Research Unit, Faculty of Allied Health Sciences, The University of Lahore Lahore, Pakistan mehboob.riffat{at}gmail.com
Posted September 05, 2020.
Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
